Full launch of twiist™ AID system powered by Tidepool brings first-ever combination of personalized insulin automation, ...
Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...
AID systems combine an insulin pump with a continuous glucose monitor to automatically adjust insulin levels throughout the day. Learn more about how they work.
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine ...
The FDA cleared the first automated insulin dosing device for adults with type 2 diabetes, the agency announced on Monday. An interoperable automated glycemic controller, Insulet's SmartAdjust ...
In a recently published study, researchers at the German Diabetes Center (DDZ) showed that automated insulin delivery (AID) systems can improve blood glucose control in people with type 1 diabetes ...
The expanded approval for the Omnipod 5 system now allows automated insulin delivery (AID) for adults with type 2 diabetes, offering a new option for better glucose management without daily injections ...
– Additional data presented at the 18th International Conference on Advanced Technologies & Treatments for Diabetes – Results published in NEJM demonstrate significant improvements in time in range ...